RC-3940-II

N/A

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameRC-3940-II
Drug Alias NameRC-3940-II
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBombesin receptor inhibitorsEpidermal growth factor receptor erbB1 inhibitors
TargetsBombesin receptorEpidermal growth factor receptor erbB1
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia & Upjohn
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia & Upjohn
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A